-
EP2732818
European procedure
Extract from the Register of European Patents
EP About this file: EP2732818
| EP2732818 - A BIPHENYLSULFONAMIDE ENDOTHELIN AND ANGIOTENSIN II RECEPTOR ANTAGONIST TO TREAT GLOMERULOSCLEROSIS [Right-click to bookmark this link] | |||
| Former [2014/21] | A diphenylsulfonamide endothelin and angiotensin II receptor agonist to treat glomerulosclerosis | ||
| [2016/28] | Status | No opposition filed within time limit Status updated on 09.03.2018 Database last updated on 26.04.2025 | |
| Former | The patent has been granted Status updated on 31.03.2017 | ||
| Former | Grant of patent is intended Status updated on 08.03.2017 | Most recent event Tooltip | 09.03.2018 | No opposition filed within time limit | published on 11.04.2018 [2018/15] | Applicant(s) | For all designated states Ligand Pharmaceuticals Inc. 3911 Sorrento Valley Boulevard Suite 110 San Diego, CA 92121 / US | [2017/40] |
| Former [2014/21] | For all designated states Ligand Pharmaceuticals Inc. 11085 North Torrey Pines Road Suite 300 San Diego, CA 92037 / US | Inventor(s) | 01 /
Zhang, Jinkun 11496 Tree Hollow Lane San Diego, CA California 92128 / US | 02 /
Dziewanowska, Zofia E 765 Bonair Place La Jolla, CA California 92037 / US | 03 /
Belder, Rene 579 Province Line Road Hopewell, NJ New Jersey 08525 / US | 04 /
Henderson, Ian 5220 Fiore Terrace, No. 405 San Diego, CA California 92122 / US | 05 /
Bogardus, Joseph B 892 Hurricane Road Keene, NY New York 12942 / US | 06 /
Zhang, Zhaoying 20 El Dorado Way Monroe NJ 08831 / US | [2014/51] |
| Former [2014/21] | 01 /
Zhang, Jinkun 11496 Tree Hollow Lane San Diego, CA California 92128 / US | ||
| 02 /
Dziewanowska, Zofia E 765 Bonair Place La Jolla, CA California 92037 / US | |||
| 03 /
Belder, Rene 579 Province Line Road Hopewell, NJ New Jersey 08525 / US | |||
| 04 /
Henderson, Ian 5220 Fiore Terrace, No. 405 San Diego, CA California 92122 / US | |||
| 05 /
Bogardus, Joseph B 892 Hurricane Road Keene, NY New York 12942 / US | |||
| 06 /
Zhang, Zhaoying 1405 Northumberland Way Monmouth Junction, NJ New Jersey 08852 / US | Representative(s) | Potter Clarkson Chapel Quarter Mount Street Nottingham NG1 6HQ / GB | [N/P] |
| Former [2017/18] | Potter Clarkson LLP The Belgrave Centre Talbot Street Nottingham NG1 5GG / GB | ||
| Former [2014/21] | Potter Clarkson LLP The Belgrave Centre Talbot Street Nottingham, NG1 5GG / GB | Application number, filing date | 14155459.2 | 29.03.2010 | [2014/21] | Priority number, date | US20090165419P | 31.03.2009 Original published format: US 165419 P | US20090165447P | 31.03.2009 Original published format: US 165447 P | [2014/21] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | EP2732818 | Date: | 21.05.2014 | Language: | EN | [2014/21] | Type: | B1 Patent specification | No.: | EP2732818 | Date: | 03.05.2017 | Language: | EN | [2017/18] | Search report(s) | (Supplementary) European search report - dispatched on: | EP | 21.03.2014 | Classification | IPC: | A61K31/422, A61P9/12, A61K9/20, A61P13/12, C07D413/12 | [2016/28] | CPC: |
A61K31/422 (EP,US);
A61K9/2013 (EP,US);
A61K9/2018 (EP,US);
A61K9/2031 (US);
A61K9/2054 (EP,US);
A61K9/2059 (EP,US);
A61P1/04 (EP);
A61P1/12 (EP);
A61P1/16 (EP);
A61P1/18 (EP);
A61P11/00 (EP);
A61P11/06 (EP);
A61P13/00 (EP);
A61P13/02 (EP);
A61P13/08 (EP);
A61P13/10 (EP);
A61P13/12 (EP);
A61P17/00 (EP);
A61P17/06 (EP);
A61P19/02 (EP);
A61P19/08 (EP);
A61P25/00 (EP);
A61P25/06 (EP);
A61P25/08 (EP);
A61P25/14 (EP);
A61P27/02 (EP);
A61P29/00 (EP);
A61P3/10 (EP);
A61P35/00 (EP);
A61P37/02 (EP);
A61P43/00 (EP);
A61P7/00 (EP);
A61P9/00 (EP);
A61P9/04 (EP);
A61P9/06 (EP);
A61P9/08 (EP);
|
| Former IPC [2014/21] | A61K31/422, A61P9/12, A61K9/20, A61P13/12 | Designated contracting states | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, SE, SI, SK, SM, TR [2014/21] | Title | German: | BIPHENYLSULFONAMIDENDOTHELIN- UND ANGIOTENSIN-II-REZEPTORANTAGONIST ZUR BEHANDLUNG VON GLOMERULOSKLEROSE | [2016/29] | English: | A BIPHENYLSULFONAMIDE ENDOTHELIN AND ANGIOTENSIN II RECEPTOR ANTAGONIST TO TREAT GLOMERULOSCLEROSIS | [2016/29] | French: | ANTAGONISTE DES RÉCEPTEURS DE L'ENDOTHÉLINE ET DE L'ANGIOTENSINE II À BASE DE BIPHÉNYLSULFONAMIDE POUR TRAITER LA GLOMÉRULOSCLÉROSE | [2016/29] |
| Former [2014/21] | Diphenylsulfonamidendothelin- und Angiotensin-II-Rezeptoragonist zur Behandlung von Glomerulosklerose | ||
| Former [2014/21] | A diphenylsulfonamide endothelin and angiotensin II receptor agonist to treat glomerulosclerosis | ||
| Former [2014/21] | Agoniste des récepteurs de l'endothéline et de l'angiotensine ii à base de diphénylsulfonamide pour traiter la glomérulosclérose | Examination procedure | 17.02.2014 | Examination requested [2014/21] | 21.11.2014 | Amendment by applicant (claims and/or description) | 24.11.2015 | Despatch of a communication from the examining division (Time limit: M06) | 01.06.2016 | Reply to a communication from the examining division | 27.06.2016 | Communication of intention to grant the patent | 12.10.2016 | Disapproval of the communication of intention to grant the patent by the applicant or resumption of examination proceedings by the EPO | 28.10.2016 | Communication of intention to grant the patent | 07.03.2017 | Fee for grant paid | 07.03.2017 | Fee for publishing/printing paid | 07.03.2017 | Receipt of the translation of the claim(s) | Parent application(s) Tooltip | EP10759268.5 / EP2413930 | Divisional application(s) | EP17157697.8 / EP3222277 | EP20152292.7 / EP3708163 | Opposition(s) | 06.02.2018 | No opposition filed within time limit [2018/15] | Fees paid | Renewal fee | 17.02.2014 | Renewal fee patent year 03 | 17.02.2014 | Renewal fee patent year 04 | 17.02.2014 | Renewal fee patent year 05 | 27.03.2015 | Renewal fee patent year 06 | 31.03.2016 | Renewal fee patent year 07 | 27.03.2017 | Renewal fee patent year 08 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [I]WO0001389 (BRISTOL MYERS SQUIBB CO [US]); | [I]US2002143024 (MURUGESAN NATESAN [US], et al) | by applicant | US5612359 | US6297233 | US6380184 | US6518292 | US6586438 | US7390824 | US7598262 | US19980007938 | US19980013952 | US19990390275 |